文献速递乳腺癌

2013至2021年中国女性乳腺癌死亡率变化趋势分析

[Analysis of changing trends in female breast cancer mortality in China from 2013 to 2021].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2025-01-01

该研究基于《中国死因监测数据集》2013—2021年数据,采用Joinpoint回归和人口拆分法分析中国女性乳腺癌死亡率趋势。粗死亡率呈上升趋势(AAPC 2.3%),标化死亡率基本平稳(AAPC -0.2%)但以2017年为折点先升后降;死亡人数增加主要归因于人口年龄结构变化(21.3%)。

要点

  • 2013—2021年中国女性乳腺癌粗死亡率上升,AAPC为2.3%(95% CI:1.7%~2.9%)。
  • 标化死亡率以2017年为折点,前期APC 3.9%,后期APC -4.1%。
  • 死亡人数增加42.8%,人口年龄结构变化贡献21.3%,非人口因素仅贡献3.2%。

核心结论

  • 2013—2021年中国女性乳腺癌粗死亡率呈持续上升趋势,主要受人口年龄结构影响,农村和中部地区粗死亡率增速较快。
  • 调整年龄结构后,中国女性乳腺癌标化死亡率从2017年开始下降。

研究设计与样本

  • 研究提取《中国死因监测数据集》中2013—2021年中国女性乳腺癌死亡数据,采用2000年中国人口普查数据标化死亡率。
  • 利用Joinpoint软件计算年度变化百分比(APC)和平均年度变化百分比(AAPC)分析趋势,采用人口拆分法定量评估人口年龄结构、人口数量和非人口因素的影响。

主要发现

  • 2013—2021年中国女性乳腺癌粗死亡率AAPC为2.3%(95% CI:1.7%~2.9%),标化死亡率AAPC为-0.2%(95% CI:-1.6%~1.3%)。
  • Joinpoint分析显示标化死亡率以2017年为折点,前期APC为3.9%(95% CI:1.1%~6.9%),后期APC为-4.1%(95% CI:-6.8%~-1.4%)。
  • 农村粗死亡率AAPC为3.0%(95% CI:2.4%~3.5%),高于城市1.3%(95% CI:0.4%~2.2%);农村标化死亡率AAPC为0.6%(95% CI:-1.0%~2.2%),城市为-1.1%(95% CI:-2.2%~0.0%)。
  • 东部、中部、西部粗死亡率AAPC分别为1.7%(95% CI:0.7%~2.8%)、3.8%(95% CI:2.5%~5.2%)、2.2%(95% CI:0.5%~4.0%);标化死亡率AAPC分别为-0.3%(95% CI:-1.7%~1.2%)、0.6%(95% CI:-1.2%~2.4%)、0.0%(95% CI:-2.2%~2.2%)。
  • 2021年死亡人数较2013年增加42.8%,人口年龄结构变化贡献21.3%,人口数量变化贡献18.3%,非人口因素仅贡献3.2%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the trend of mortality rates for female breast cancer in China and quantify the impact of demographic and non-demographic factors on the burden of breast cancer mortality. Methods: Mortality data for female breast cancer from 2013 to 2021 were extracted from the Chinese Cause of Death Monitoring Dataset, and the 2000 Chinese population census data were used to standardize the mortality rates. The Joinpoint software was employed to analyze the mortality trends by calculating the Annual Percentage Change (APC) and Average Annual Percentage Change (AAPC). The population decomposition method was utilized to quantify the impact of changes in population age structure, population size, and non-demographic factors on the burden of breast cancer mortality. Results: From 2013 to 2021, the crude mortality rate for female breast cancer in China showed an increasing trend, with an AAPC of 2.3% (95% CI: 1.7%-2.9%). The standardized mortality rate remained relatively stable, with an AAPC of -0.2% (95% CI: -1.6%-1.3%). However, Joinpoint trend analysis indicated that the standardized mortality rate had a turning point in 2017, with a rapid increase before this year (APC: 3.9%, 95% CI: 1.1%-6.9%), and a rapid decline after this year (APC: -4.1%, 95% CI: -6.8% to -1.4%). The growth speed of crude mortality rates in rural areas was higher than that in urban areas, with AAPCs of 3.0% (95% CI: 2.4%-3.5%) and 1.3% (95% CI: 0.4%-2.2%), respectively. The standardized mortality rate in rural areas remained relatively stable, with an AAPC of 0.6% (95% CI: -1.0%-2.2%), while in urban areas, it showed a decreasing trend, with an AAPC of -1.1% (95% CI: -2.2%-0.0%). In the eastern, central, and western regions, the crude mortality rates all showed an increasing trend, with AAPCs of 1.7% (95% CI: 0.7%-2.8%), 3.8% (95% CI: 2.5%-5.2%), and 2.2% (95% CI: 0.5%-4.0%), respectively, while the standardized mortality rates remained relatively stable, with AAPCs of -0.3% (95% CI: -1.7%-1.2%), 0.6% (95% CI: -1.2%-2.4%), and 0.0% (95% CI: -2.2%-2.2%), respectively. Compared with 2013, the number of deaths in 2021 increased by 42.8%, of which changes in population age structure accounted for 21.3%, the age structure changes of urban and rural residents contributed 22.8% and 19.2%, respectively, to the whole changes caused by population age structure, while those in the eastern, central, and western regions contributed 20.6%, 24.3%, and 15.9%, respectively.Demographically, the changes in population size accounted for 18.3%, and non-demographic factors only accounted for 3.2%. Conclusions: From 2013 to 2021, the crude mortality rate for female breast cancer in China continued to rise, a trend mainly influenced by population age structure, with the fastest growth rates in crude mortality rates observed in rural areas and the central region. After adjusted for age structure, the standardized mortality rate for female breast cancer in China began to decline from 2017. 目的: 探讨中国女性乳腺癌死亡率的变化趋势,并量化评估人口因素和非人口因素对乳腺癌死亡负担的影响。 方法: 提取《中国死因监测数据集》中2013—2021年中国女性乳腺癌的死亡数据,采用2000年中国人口普查数据对死亡率进行标化。利用Joinpoint软件对死亡趋势进行分析,计算年度变化百分比(APC)和平均年度变化百分比(AAPC)。采用人口拆分法量化评估人口年龄结构、人口数量和非人口因素变化对乳腺癌死亡负担的影响。 结果: 2013—2021年中国女性乳腺癌粗死亡率呈上升趋势,AAPC为2.3%(95% CI:1.7%~2.9%),乳腺癌标化死亡率基本保持平稳,AAPC为-0.2%(95% CI:-1.6%~1.3%)。但Joinpoint趋势分析显示,中国女性乳腺癌标化死亡率以2017年为折点,前期上升迅速,APC为3.9%(95% CI:1.1%~6.9%),后期迅速下降,APC为-4.1%(95% CI:-6.8%~-1.4%)。农村女性乳腺癌粗死亡率增长速度高于城市,AAPC分别为3.0%(95% CI:2.4%~3.5%)和1.3%(95% CI:0.4%~2.2%)。农村女性乳腺癌标化死亡率基本保持平稳,AAPC为0.6%(95% CI:-1.0%~2.2%),城市女性乳腺癌标化死亡率呈下降趋势,AAPC为-1.1%(95% CI:-2.2%~0.0%)。东部、中部和西部地区女性乳腺癌粗死亡率均呈上升趋势,AAPC分别为1.7%(95% CI:0.7%~2.8%)、3.8%(95% CI:2.5%~5.2%)和2.2%(95% CI:0.5%~4.0%),标化死亡率基本保持平稳,AAPC分别为-0.3%(95% CI:-1.7%~1.2%)、0.6%(95% CI:-1.2%~2.4%)和0.0%(95% CI:-2.2%~2.2%)。2021年中国女性乳腺癌死亡人数比2013年增加了42.8%,其中人口年龄结构变化导致女性乳腺癌死亡人数增加了21.3%,城市和农村人口年龄结构变化使女性乳腺癌死亡人数分别增加了22.8%和19.2%,东部、中部和西部地区人口年龄结构变化使女性乳腺癌死亡人数分别增加了20.6%、24.3%和15.9%;人口数量变化使女性乳腺癌死亡人数增加了18.3%;而非人口因素仅使女性乳腺癌死亡人数增加了3.2%。 结论: 2013—2021年中国女性乳腺癌粗死亡率呈持续上升趋势,这一趋势主要受到人口年龄结构的影响,其中农村和中部地区女性乳腺癌粗死亡率的增速较快。调整年龄结构后,中国女性乳腺癌标化死亡率从2017年开始下降。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Gao T, Li C, Yao YF, et al. [Analysis of changing trends in female breast cancer mortality in China from 2013 to 2021]. Zhonghua Zhong Liu Za Zhi. 2025. PMID: 40375588. doi:10.3760/cma.j.cn112152-20240530-00227

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。